
Kriti Nutrients Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
Kriti Nutrients CMP Rs.77. Q1 FY27E revenue Rs.273-314 Cr. PAT estimate Rs.10-13 Cr. 12-month target Rs.92-102.
Updated: 9 Jul 2026 • 11:35 am
Posted by:

Kriti Nutrients Q1 Results FY27 is coming into focus as investors position ahead of the July-August 2026 results season, with Kriti Nutrients shares trading at Rs.77 against a market capitalisation of Rs.393 Cr and a price-to-earnings multiple of Not meaningful. As a FMCG name on the NSE and BSE, Kriti Nutrients enters the Kriti Nutrients Q1 Results FY27 print with the Street watching revenue momentum, margin trajectory and management commentary on FY27 guidance.
This Kriti Nutrients Q1 Results FY27 preview is built on a trailing-growth framework applied to the company’s Q1 FY26 base of Rs.231 Cr revenue and Rs.9 Cr net profit, using the most recent year-on-year growth signal from Q4 FY26. This Q1 prediction is a Uniresearch trailing-growth projection, not a formal analyst estimate, and should be read alongside the company’s own guidance once released.
Get Free Investment Predictions and Kriti Nutrients Research at Univest
About Kriti Nutrients
Kriti Nutrients (NSE: KRITINUT) operates in the FMCG space and is tracked on Univest under its NSE and BSE listings. Ahead of the Kriti Nutrients Q1 Results FY27 print, the company’s most recent reported quarter (Q4 FY26) shows revenue of Rs.257 Cr and net profit of Rs.6 Cr, forming the base against which the Kriti Nutrients Q1 Results FY27 estimates in this article are built. This Kriti Nutrients Q1 Results FY27 snapshot is intended as a starting point for research, not a substitute for the company’s own disclosures.
Kriti Nutrients Q1 FY27 Estimates
| Metric | Q1 FY27E (Range) | Q1 FY26 Actual | YoY Growth |
|---|---|---|---|
| Revenue (Rs. Cr) | 273-314 | 231 | +27.2% |
| Net Profit / PAT (Rs. Cr) | 10-13 | 9 | +25.1% |
| Results Date | July-August 2026 (indicative) | ||
| 12-Month Target (Uniresearch Estimate) | Rs.92-102 | ||
Univest, a SEBI-Registered Investment Advisor, Tracks Kriti Nutrients Ahead of Q1 FY27 Results
Key Catalysts to Watch
1. Rural Demand Recovery
Rural demand recovery and price hikes supporting revenue growth for the quarter is one of the primary variables that analysts are tracking ahead of Kriti Nutrients’s Q1 FY27 results and FY27 guidance. The market’s reaction to management commentary on this factor will likely determine whether the stock can sustain a move toward the Kriti Nutrients share price target or faces renewed pressure.
2. Input Cost Moderation
Input cost moderation aiding gross margin versus the year-ago period is one of the primary variables that analysts are tracking ahead of Kriti Nutrients’s Q1 FY27 results and FY27 guidance. The market’s reaction to management commentary on this factor will likely determine whether the stock can sustain a move toward the Kriti Nutrients share price target or faces renewed pressure.
3. Distribution Expansion
Distribution expansion and new launches widening the portfolio reach is one of the primary variables that analysts are tracking ahead of Kriti Nutrients’s Q1 FY27 results and FY27 guidance. The market’s reaction to management commentary on this factor will likely determine whether the stock can sustain a move toward the Kriti Nutrients share price target or faces renewed pressure.
Download the Univest iOS App or Univest Android App to track Kriti Nutrients’s live price and Q1 FY27 result updates.
Key Risks to the Kriti Nutrients Q1 Results FY27 Outlook
- Input cost inflation in key raw materials pressuring gross margin.
- Slower rural demand recovery affecting volume growth.
- Intensifying competition from regional and unorganised players.
Q4 FY26 Performance Context for the Kriti Nutrients Q1 Results FY27 Print
Kriti Nutrients closed Q4 FY26 with revenue of Rs.257 Cr and net profit of Rs.6 Cr, a year-on-year revenue change of +27.2% and PAT change of +25.1% versus Q4 FY25. This base underpins the Kriti Nutrients Q1 Results FY27 projection used in this preview and should be read alongside the company’s own Kriti Nutrients Q1 Results FY27 commentary once reported.
Technical Analysis Ahead of Kriti Nutrients Q1 Results FY27
Kriti Nutrients shares last traded at Rs.77. For the current 52-week high and low, support and resistance levels, investors should check the live chart on the Univest app or the NSE website, since these levels move intraday and are not reproduced here to avoid stale data.
Share Price Target Based on the Kriti Nutrients Q1 Results FY27 Outlook
3-6 Month Target
Over a 3-6 month horizon, the Kriti Nutrients Q1 Results FY27 trailing-growth framework points to a range of Rs.80-86 for Kriti Nutrients, contingent on the Kriti Nutrients Q1 Results FY27 print matching or beating the trailing growth trend.
12-Month Target
The 12-month target (Uniresearch estimate) tied to this Kriti Nutrients Q1 Results FY27 view for Kriti Nutrients works out to Rs.92-102, built on the same trailing revenue growth trend and current valuation multiple. Tracking with a constructive bias is how Univest research categorises the stock heading into Kriti Nutrients Q1 Results FY27, not a formal Buy or Sell call.
FY27-28 Outlook
Looking out to FY27-28, a sustained continuation of the growth trajectory implied by this Kriti Nutrients Q1 Results FY27 analysis would put Kriti Nutrients in a Rs.105-119 range, though this is sensitive to sector-wide demand, cost trends and any change in the company’s competitive position.
What to Watch in the Kriti Nutrients Q1 Results FY27 Print
- Revenue and PAT versus the Kriti Nutrients Q1 Results FY27 estimate range in this preview.
- Management commentary on FY27 growth guidance and margin trajectory relevant to the Kriti Nutrients Q1 Results FY27 narrative.
- Rural demand recovery and price hikes supporting revenue growth for the quarter
- Input cost inflation in key raw materials pressuring gross margin
Conclusion on Kriti Nutrients Q1 Results FY27
Kriti Nutrients enters the Q1 FY27 results season trading at Rs.77, with the 12-month Uniresearch target range of Rs.92-102 reflecting a tracking with a constructive bias stance. Investors tracking the Kriti Nutrients Q1 Results FY27 print should watch the catalysts and risks above and consult a SEBI-registered advisor before making investment decisions around the results.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Kriti Nutrients Q1 Results FY27
When are Kriti Nutrients Q1 FY27 results expected?
Ans. Kriti Nutrients’s Q1 FY27 results are expected in the July-August 2026 window, in line with the broader NSE and BSE results season for the quarter ending June 2026.
What is the Kriti Nutrients Q1 FY27 revenue estimate?
Ans. The Uniresearch trailing-growth estimate for Kriti Nutrients’s Q1 FY27 revenue is Rs.273-314 Cr, based on the Q1 FY26 base of Rs.231 Cr.
What is the Kriti Nutrients share price target?
Ans. The 12-month Uniresearch estimate for Kriti Nutrients share price target is Rs.92-102, based on trailing growth and current valuation multiples.
Is Kriti Nutrients a good buy before Q1 FY27 results?
Ans. Kriti Nutrients is tracking with a constructive bias heading into Q1 FY27 results. Investors should weigh the catalysts and risks in this article and consult a SEBI-registered advisor before investing.
What should investors watch in Kriti Nutrients’s Q1 FY27 results?
Ans. Key items include revenue and PAT versus estimates, management commentary on FY27 guidance, and rural demand recovery and price hikes supporting revenue growth for the quarter.
Where can I track Kriti Nutrients share price live?
Ans. Kriti Nutrients share price can be tracked live on the Univest app and website, along with research updates from SEBI-registered analysts.
Recent Articles

Chandan Healthcare Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
9 July 2026

DIC India Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
9 July 2026

Glottis Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
9 July 2026

Vinyl Chemicals India Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
9 July 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Chandan Healthcare Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
DIC India Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
Glottis Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
Vinyl Chemicals India Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
Divine Hira Jewellers Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
Popular this week
Chandan Healthcare Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
DIC India Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
Glottis Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
Vinyl Chemicals India Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target
Divine Hira Jewellers Q1 Results FY27: Date, Revenue Estimates, Key Catalysts and Share Price Target

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





